ArticleBMC complementary and alternative medicine2018

Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology.

Zhitong Bing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.